Premium
Supraventricular tachycardia after withdrawal of prolonged dexmedetomidine infusion in a paediatric patient without heart disease
Author(s) -
FloresGonzález J. Carlos,
EstalellaMendoza Ana,
LechugaSancho Alfonso M.,
HernándezGonzález Arturo,
RubioQuiñones Fernando,
RodríguezCampoy Patricia,
SaldañaValderas Mónica
Publication year - 2017
Publication title -
journal of clinical pharmacy and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 73
eISSN - 1365-2710
pISSN - 0269-4727
DOI - 10.1111/jcpt.12564
Subject(s) - medicine , dexmedetomidine , supraventricular tachycardia , anesthesia , respiratory distress , heart disease , tachycardia , adverse effect , paroxysmal supraventricular tachycardia , acute respiratory distress , bradycardia , cardiology , heart rate , sedation , lung , blood pressure
Summary What is known and objective Dexmedetomidine ( DEX ) has been reported to be safe in paediatric patients. Case description We present the case of a girl without heart disease admitted at our PICU due to an influenza A acute respiratory distress syndrome, who suffered a paroxysmal supraventricular tachycardia ( PSVT ) twelve hours after DEX progressive withdrawal was completed. What is new and Conclusion This is the first report of PSVT as an adverse reaction to DEX in a paediatric patient without heart disease.